Hawaii Administrative Rules
Title 11 - DEPARTMENT OF HEALTH
Subtitle 1 - GENERAL DEPARTMENTAL PROVISIONS
Chapter 113 - SUBSTANCE ABUSE TESTING BY LABORATORIES
Section 11-113-2 - Definitions

As used in this chapter:

"Alcohol" means ethyl alcohol.

"Chain of custody" means procedures to account for the integrity of each specimen by tracking its handling and storage from point of specimen collection to final disposition of the specimen.

"Collection site" means a place where the individual presents himself or herself for the purpose of providing a urine or blood specimen for substance abuse testing.

"Collection site person" means a person who instructs and assists individuals at a collection site and who receives and makes an initial examination of the urine specimens provided by those individuals.

"Collector of blood specimens" means a person who collects a blood specimen pursuant to section 11-113-7.

"Confirmatory test" means a controlled substance or alcohol test that uses a method of analysis determined by the director of health to be reliable in establishing the identity and quantity of alcohol, drugs, or metabolites of drugs in the specimen.

"Cutoff level" means that concentration of a substance, established by the director, in a specimen below which dictates a negative result for that test.

"Department" means the department of health, State of Hawaii.

"Director" or "director of health" means the director of the department of health.

"Drug" means a controlled substance as defined in chapter 329, Hawaii Revised Statutes.

"False positive" means reporting the presence of a drug or its metabolite or alcohol which is not present at or above the cutoff level.

"Medical review officer" means an individual, licensed by the department, who has knowledge of substance abuse disorders and toxicology as determined by the department, and is appointed by the third party to receive, review, and interpret the results of laboratory tests requested by the third party.

"Negative specimen" means a specimen which was found to have negative test results for all substances for which the specimen was tested.

"Negative test result" means either a finding by testing of the absence of drugs, alcohol, or the metabolites of drugs, or their presence below the cutoff levels, in the specimen tested, or a positive test result which the medical review officer determines to be not attributable to substance abuse.

"ng/ml" means nanograms per milliliter of liquid specimen.

"Positive specimen" means a specimen which is found to have a positive test result.

"Positive test result" means a finding by confirmatory testing of the presence of drugs, alcohol, or the metabolites of drugs in the specimen tested in levels at or above the cutoff levels.

"Presumptive positive test result" means a finding, by a screening test, of the presence of drugs or the metabolites of drugs at or above the cutoff levels.

"Specimen" means urine, blood, or any other bodily substance that the department determines to be appropriate for substance abuse testing.

"Screening test" means a laboratory test to eliminate negative specimens from further consideration.

"State" means State of Hawaii unless otherwise specified.

"Substance abuse test" means any testing procedure designed to take and analyze body fluids or materials from the body for the purpose of measuring the amount of drugs, alcohol, or the metabolites of drugs in the specimen tested.

"Third party" means any person, agency, employer or any other entity who requests substance abuse testing of another person or persons. Unless otherwise specified, "third party" shall include the party's designated staff.

"Verified positive test result" means a determination by the medical review officer that a positive test result for drugs, the metabolites of drugs, or alcohol can be attributed to substance abuse in the levels specified in § 11-113-18.